Aims: Huntington's disease (HD) is a neurodegenerative disorder characterized by progressive abnormalities in cognitive function, mental state, and motor control. HD is characterized by a failure in brain energy metabolism. It has been proposed that monocarboxylates, such as lactate, support brain activity. During neuronal synaptic activity, ascorbic acid released from glial cells stimulates lactate and inhibits glucose transport. The aim of this study was to evaluate the expression and function of monocarboxylate transporters (MCTs) in two HD models.
| INTRODUC TI ON
Huntington's disease (HD) is a neurodegenerative disorder which exhibits an autosomal dominant inheritance. 1, 2 HD is characterized by widespread neurodegeneration with preferential deterioration of medium-sized spiny neurons (MSNs) in the striatum. It is caused by an unusual expansion of the trinucleotide sequence cytosineadenosine-guanosine (CAG) in exon 1 of the huntingtin gene. 3 In affected people, the triplet is present more than 35 times. 4 The huntingtin gene codes for a protein called huntingtin (Htt). This is a soluble 384-kDa protein, essential for embryogenesis, and is ubiquitously expressed in moderate amounts in the nervous system as well as in other systems. Huntington's disease is characterized by a failure in brain energy metabolism. Positron emission tomography studies show drastic reductions in glucose metabolism in the basal ganglia and cerebral cortex of symptomatic HD patients. 7 Reduced TCA cycle activity and oxidative phosphorylation, 8 decreased glyceraldehyde 3-phosphate dehydrogenase activity, 9 impaired oxidative phosphorylation enzyme activity 10 and downregulation of peroxisome proliferatoractivated receptor-γ 11 have also been described. Decreased expression of the neuronal glucose transporter GLUT3 also occurs in HD. 12, 13 The brain is a metabolically active organ. Special attention has been focused on the role of monocarboxylates in supporting brain activity, in particular the Astrocyte-Neuron Lactate Shuttle (ANLS). 14 The ANLS proposes that under resting conditions, neurons consume glucose, whereas during synaptic activity, they preferentially consume lactate. The key to this energetic coupling is the metabolic activation that occurs in astrocytes. Glutamate released from neurons stimulates glucose uptake, 15 glycolysis, 16 lactate release, 15 and ascorbic acid depletion in astrocytes.
17
According to our data, ascorbic acid may function as a metabolic switch by inhibiting glucose consumption during episodes of glutamatergic synaptic activity 18, 19 and stimulating lactate uptake in neurons. 18, 20 The monocarboxylate transporter MCT2 is essential for neuronal lactate uptake. 21, 22 In HD, the ascorbic acid metabolic switch and ANLS do not function correctly. 23 Indeed, inhibited uptake of lactate and other monocarboxylates did not affect synaptic activity in neurons expressing mutant Htt. 23 The first aim of this study was to examine the expression, function, and modulation of monocarboxylate transporters (MCTs) by ascorbic acid in mouse and cellular models of HD.
The MCTs correspond to gene SLC16 family. 24 MCT1, MCT2, MCT3, and MCT4 show affinity for monocarboxylates. 24, 25 MCT1 is highly expressed in postnatal periods in all cell types of the brain.
26
In adult brain, the expression of MCT1 decreases in neurons and increases in astrocytes. 27 MCT1 is also expressed in endothelial cells of the blood-brain barrier, choroid plexuses, and ependymal cells.
28
MCT2 is a high-affinity lactate transporter, and its expression occurs mainly in neurons, increasing with neuronal maturation. 
| Cell cultures

| Uptake assays using radiolabeled lactate
Uptake assays were performed in 500 μL of incubation buffer (IB 
| Biotinylation of surface proteins
Biotinylation assays were performed as previously was described 
| Western blot analysis
| Immunofluorescence analysis
| Lactate uptake using live cell imaging
Lactate uptake was visualized using a H + sensitive probe, BCECF, 
| Plasmids and transfection
Plasmid constructs, GLUT3-EGFP, encoding full-length rat GLUT3
fused at the C termini to EGFP were kindly provided by Dr. J.P.
Bolaños (Departamento de Bioquímica y Biología Molecular, Universidad de Salamanca, Spain). GLUT3-mCherry, encoding fulllength GLUT3 fused at the C termini to mCherry (red fluorescent protein) was subcloned from GLUT3-EGFP to pcDNA 3.1-mCherry using Xba and XhoI restriction enzymes. Laconic was acquired from Addgene (#44238). Cells maintained in Optimem defined media were transfected using Lipofectamine 2000 (Gibco Invitrogen
Corporation, Grand Island, NY, USA).
| Statistical analyses
Statistical comparison between two or more groups of data was respectively performed using Student's t test or analysis of variance (ANOVA) followed by the Bonferroni posttest. Linear and nonlinear regressions were calculated using SigmaPlot v9.0 software (only correlations >0.8 were accepted).
| RE SULTS
We examined MCT expression in R6/2 mice to determine why syn- Figure 1A,D) . MCT1 was mainly localized in structures that appeared to be blood vessels ( Figure 1B ) and ependymal cells ( Figure 1C ) in immunofluorescence analyses. MCT2 was localized in striatal neurons ( Figure 1E ) and also in pyramidal neurons from CA1 hippocampus ( Figure 1F ). MCT1 expression has been described in ependymal cells, endothelial cells, and the end feet of astrocytes. were used as controls. Results were normalized using specific primers to amplify mRNAs coding for GAD67 (striatal neuronal marker) and GFAP (astroglial marker). Analysis of variance (ANOVA) followed by the Bonferroni posttest, n = 3. (B,E) Immunofluorescence analyses for MCT1 (green) and MCT2 (green) in the striatum of presymptomatic and symptomatic R6/2 mice. Representative images of four independent experiments. Nuclei were stained using TO-PRO-3. Scale bar is 10 μm. (C,F) Specific reactivity of MCT antibodies in ependymal cells and hippocampal neurons. Nuclei were stained using TO-PRO-3. Scale bar is 50 μm
To study the possibility that neuronal lactate transport is impaired in HD, we studied MCT expression and function in STHdhQ7 31 We will refer to WT and mutant cells as Q7 and Q111 cells, respectively. As for R6/2 mice, qPCR analyses showed no significant differences in MCT1 and MCT2 mRNA levels between Q111 and Q7 cells (Figure 2A,D) . The same behavior was observed by
Western blot analyses ( Figure 2B,E) . Immunofluorescence analyses showed immunoreactivity throughout the cell body ( Figure 2C ,F).
MCT1 immunoreactivity was more abundant at the plasma membrane in both Q7 and Q111 cells ( Figure 2C ), while MCT2 exhibited cytoplasmic immunoreactivity ( Figure 2F ).
The expression of monocarboxylate transporters in Q7 and 
30,35
Lactate transport in Q cells was almost completely abolished by AR-C ( Figure 3D-F Figure 4) . Therefore, the number of transporters at the cellular surface is not altered, implying increased MCT2 efficiency.
ANLS does not seem to be working correctly in HD. Indeed, synaptic activity in neurons expressing mutant Htt is not affected when monocarboxylate uptake is inhibited. 23 However, HD neurons could express a highly efficient MCT2. Lactate uptake and glucose uptake cannot occur simultaneously. 18 In WT neurons, lactate uptake is possible because glucose uptake is inhibited by ascorbic acid during synaptic activity. 19 Thus, ascorbic acid can stimulate lactate uptake in WT neurons ( Figure 5A ). 20 This effect was not observed in cells expressing mutant Htt ( Figure 5A ). Lactate is transported across cell membranes by diffusional, saturable cotransport with protons, mediated by MCTs. Ascorbic acid inhibits glucose uptake by a GLUT3-dependent mechanism 38 and HD neurons and Q111 cells exhibit a decrease in GLUT3
expression. 12 Therefore, we reasoned that the failure in ascorbic aciddependent stimulation of lactate uptake could be a consequence of inhibited glucose transport. In other words, in HD cells ascorbic acid is unable to inhibit glucose uptake, and therefore, it is unable to stimulate lactate transport. To test this hypothesis, we used C6 cells (brain glioma) which endogenously express GLUT3. Figure 7A,B) . Thus, the ablation of GLUT3 expression using a specific shRNA (fully characterized in Beltrán et al 
| D ISCUSS I ON
Monocarboxylates are essential for sustaining neuronal energy metab- adaptation to the demand of synaptic activity.
48 MCT14 expression has been described in neuronal somas. 47 However, phylogenetic analysis supports the idea that MCT14 should be a neuronal aromaticamino-acid transporter.
47
The anchorage and activity of MCTs at the plasma membrane requires interaction with a chaperone protein such as basigin/CD147
and embigin/gp70. 49 The ancillary protein for MCT2 is embigin/ with 0 mmol/L (control) or 1 mmol/L ascorbic acid prior to the assay. The data represent the mean ± SD of three experiments. ANOVA followed by Bonferroni, **P < 0.01, *P < 0.05
Thus, it is possible to speculate that changes in embigin could explain changes in MCT2 activity.
Expression of MCT1, 2, and 4 (data not shown) is not altered in HD. This could be a compensatory mechanism to rectify altered glucose metabolism in HD. 23 The expression of the neuronal glucose transporter, GLUT3, is decreased in HD. 12 However, in HD the astrocyte-neuron metabolic interactions are altered. 23 Changes in neuronal metabolism also occur between the brain in resting state and periods of activity. 18, 39 During conditions of glutamatergic synaptic activity, neurons preferentially use MCTs, such as lactate, to sustain synapse function. 19 Under neuronal activity, lactate uptake is increased while glucose uptake is inhibited. This phenomenon occurs because neurons synaptically active induce an increase in ascorbic acid uptake, which is released from glial cells in response to extracellular glutamate. 18 Intracellular ascorbic acid in neurons inhibited glucose uptake through GLUT3. As shown here, inhibition of glucose uptake is sufficient to induce increased lactate transport. Therefore, considering altered ascorbic acid uptake and altered MCT2 and GLUT3 
